Wednesday, 24 May 2017

Korea News

  • F&S: S. Korea will be biosimilars leader by 2020

    Korea |  Analysis | By BioSpectrum Bureau | 0 Comment

    ‎Singapore: Since South Korea introduced a regulatory pathway for manufacturing biologics in 2009, the government has raised its stakes in the biosimilars market. It is providing both...Read more

  • Is a new therapy for diabetes on the way?

    Korea |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: In a breakthrough discovery, Korean scientists have identified that regulating the effect of a protein related to the detoxification function of the liver, can improve diabetes. ...Read more

  • 3SBio to develop antibody for acute leukemia

    Korea |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Chinese biotechnology firm, 3SBio, has signed an exclusive license with Korean firm, DiNonA  for the development, manufacturing and marketing of Leukotuximab. It is an anti JL-1...Read more

  • Taiho terminates oranitib Ph III trial

    Korea |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Faced with disappointing results, Japan's large drugmaker, Taiho Pharmaceutical has said that it is terminating a Phase III clinical trial of the angiogenesis inhibitor TSU-68 (o...Read more

  • Japanese, Korean firm to jointly develop breast cancer drug

    Korea |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Japanese company, Kyowa Hakko Kirin and Korean firm, Syndax Pharmaceuticals, have entered into a license agreement for the exclusive rights to develop and commercialize entinosta...Read more

  • Korean doctors skeptical about Telemedicine

    Korea |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Korean doctors have expressed concern over the controversial telemedicine bill that is expected to be effective by next year. Doctors opine that they will no longer be able to pr...Read more

  • Swedish firm partners with Sanofi to expand in Asia

    Korea |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Sweden-based company NeuroVive Pharmaceutical's Asia arm has signed a collaboration agreement with Sanofi's affiliate for the development and commercialization of CicloMulsion in...Read more

  • Korea, Ontario Centers collaborate on tech research

    Korea |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: The Korea Evaluation Institute of Industrial Technology (KEIT) has inked a Memorandum of Understanding with the Ontario Centers of Excellence (OCE), to collaborate and develop te...Read more

  • Korea close to discovering HIV cure

    Korea |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Scientists have finally discovered an enzyme that could curb the increasing menace of HIV and promise a possible cure in the future. A group of Korean medical researchers have di...Read more

  • Y brain Korea receives $3.5mn Series A funding

    Korea |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Korea-based healthcare wearables start-up firm, Y brain, has raised $3.5 million in Series A funding for its novel wearable device that can treat neurological disorders. Y brain...Read more

  • Korean vaccine market to grow by 11.5 percent

    Korea |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: With pandemics lurking at the back, achieving vaccine independence has become an essential part towards health security. However in comparison to Japan, US and Europe, Korea is ...Read more

  • Demand for generics in Asia is drawing pharma majors

    Korea |  Opinion | By BioSpectrum Bureau | 0 Comment

    The clinical trials market in the Asia Pacific (APAC) region has been steadily growing with increased focus primarily on India and China, with South Korea, Singapore and Taiwan being the ot...Read more

  • Merck-Samsung biosimilar receives Korea nod

    Korea |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Korea's Food and Drug Safety has approved BRENZYS, a biosimilar of the immunology medicine Enbrel, for the treatment of arthritis. The approval marks Samsung- Merck's first biosi...Read more

  • Korea to nurture its medical tourism industry

    Korea |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: According to the nation's top health official, the Korean government is keen to promote its medical tourism industry and aims to multiply the current number of medical tourists t...Read more

  • Samsung Medison launches first premium ultrasound system in Australia

    Korea |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Korea-based medical devices company Samsung Medison has announced showcasing of two new ultrasound systems including the UGEO WS80A, the first premium ultrasound device for OB/GY...Read more

  • Allegro collaborates with Hanmi pharmaceutical

    Korea |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Allegro Ophthalmics, a Korea-based pharma major has inked a license pact with Hanmi pharmaceuticals to advance and accelerate the global development program for Luminate, Allegro...Read more

  • SK Telecom enters China's lucrative market

    Korea |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: SK Telecom aims to tap the lucrative Chinese market by opening two healthcare centers 'SK Telecom Healthcare R&D Center' and 'Shenzhen VISTA-SK Medical Center' in Software P...Read more

  • Heartbeat grows 350% year-over-year

    Korea |  News | By BioSpectrum Bureau | 0 Comment

    Singapore: Heartbeat Experts, the global leader in stakeholder management solutions for the life sciences industry has announced its first quarter results for the year. The company has reco...Read more

Survey Box

Will biobanking change healthcare in the world?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls